Masimo Corp

Chart & Performance

D1W1MN

P/E

108.76

P/S

4.33

EPS

1.52

Div Yield, %

0.00%

Shrs. gr., 5y

-0.70%

Rev. gr., 5y

19.00%

Revenues

2.05b

+0.60%

Net income

82m

-43.21%

CFO

94m

+218.98%

Dividend

Nov 23, 20121 USD/sh

Profile

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. It offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. It offers connectivity devices; and nasal high flow ventilation and neuromodulation solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. The company was incorporated in 1989 and is headquartered in Irvine, California.

URL

https://www.masimo.com/

IPO date

Aug 08, 2007

Employees

4,000

Domiciled in

Incorporated in

Valuation

Order:

Title USD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title USD in thousands, except ratios and share amounts	2023‑12	2022‑12	2022‑00	2021‑00	2019‑12	2018‑12	2017‑12	2016‑12	2016‑00
Income
Revenues	2,048,100 65.28%	2,035,800 77.99%
Cost of revenue	1,901,400	1,825,800
Unusual Expense (Income)
NOPBT	146,700	210,000
NOPBT Margin	7.16%	10.32%
Operating Taxes	6,600	49,900
Tax Rate	4.50%	23.76%
NOPAT	140,100	160,100
Net income	81,500 -64.50%	143,500 -40.28%
Dividends
Dividend yield
Proceeds from repurchase of equity	7,000	(393,400)
BB yield	-0.11%	4.82%
Debt
Debt current	70,700	33,800
Long-term debt	981,500	1,013,700
Deferred revenue	26,400	25,000
Other long-term liabilities	32,900	111,500
Net debt	777,300	830,800
Cash flow
Cash from operating activities	94,100	29,500
CAPEX	(44,000)	(56,300)
Cash from investing activities	(81,200)	(1,057,600)
Cash from financing activities	(57,100)	520,300
FCF	(430,710)	(247,532)
Balance
Cash	163,000	202,900
Long term investments	111,900	13,800
Excess cash	172,495	114,910
Stockholders' equity	1,750,600	1,725,900
Invested Capital	2,239,805	2,263,490
ROIC	8.94%	10.24%
ROCE	5.76%	8.26%
EV
Common stock shares outstanding	54,100	55,200
Price	117.21 -59.97%	147.95 -44.87%
Market cap	6,341,061 -62.45%	8,166,840 -47.57%
EV	7,118,361	8,997,640
EBITDA	245,000	346,100
EV/EBITDA	29.05	26.00
Interest	50,300	25,700
Interest/NOPBT	34.29%	12.24%